← Evidence map

ArticleNature biotechnology2018

Sangamo's landmark genome editing trial gets mixed reception.

Cormac SheridanPubMed ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30307929